Cargando…
Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial
Objective To examine the protective efficacy of measles vaccination in infants in a low income country before 9 months of age. Design Randomised clinical trial. Participants 1333 infants aged 4.5 months: 441 in treatment group and 892 in control group. Setting Urban area in Guinea-Bissau. Interventi...
Autores principales: | Martins, Cesário L, Garly, May-Lill, Balé, Carlito, Rodrigues, Amabelia, Ravn, Henrik, Whittle, Hilton C, Lisse, Ida M, Aaby, Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2500198/ https://www.ncbi.nlm.nih.gov/pubmed/18653640 http://dx.doi.org/10.1136/bmj.a661 |
Ejemplares similares
-
A Randomized Trial of a Standard Dose of Edmonston-Zagreb Measles Vaccine Given at 4.5 Months of Age: Effect on Total Hospital Admissions
por: Martins, Cesario L., et al.
Publicado: (2014) -
Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial
por: Aaby, Peter, et al.
Publicado: (2010) -
The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy
por: Aaby, Peter, et al.
Publicado: (2012) -
Measles Vaccination in the Presence or Absence of Maternal Measles Antibody: Impact on Child Survival
por: Aaby, Peter, et al.
Publicado: (2014) -
Interaction between neonatal vitamin A supplementation and timing of measles vaccination: A retrospective analysis of three randomized trials from Guinea-Bissau()
por: Benn, Christine S., et al.
Publicado: (2014)